Pyoderma Gangrenosum - Clinical Aspects, Treatment
Authors:
D. Jarčušková; K. Benečová; M. Ficová; J. Jautová
Authors‘ workplace:
Dermatovenerologická klinika LF a FNsP, Košice, prednostka doc. MUDr. J. Jautová, PhD.
Published in:
Čes-slov Derm, , 2002, No. 2, p. 80-83
Category:
Overview
The authors describe a group of six patients with pyoderma gangrenosum. In three woman the ulcerative form was on the leg, in one woman the vesicular form changing finto ulcers on the instep of the foot and leg, in one woman the pustulous form on the anterior and posterior surface of the chest and in one man the vegetating form on the chest and lower extremities. Associated diseases were in two instances chronic myeloid leukaemia, once m. Hodgkin, once rheumatoid arthritis, once cholecystitis and chronic hepatitis, once BK positive TB of the lungs stabilized for 10 years. Treatment with systemic cortisonoids was not successful. A verv favourable therapeutic effect was achieved with cyclosporin A - 2.5 mg/kg/day with gradual reduction of the dose to a maintenance dose of 50 mg/day. In four patients the slon manifestations healed within 4 to 24 months. In two patients marked improvement of clinical and slon manifestations occurred within 9 to 22 months. Side-effects of Teatment were not revealed by laboratory and clinical monitoring.
Key words:
pyoderma gangrenosum - cyclosporin A
Labels
Dermatology & STDs Paediatric dermatology & STDsArticle was published in
Czech-Slovak Dermatology
2002 Issue 2
Most read in this issue
- Pyoderma Gangrenosum - Clinical Aspects, Treatment
- Contribution to the Diagnostics and Therapy of Autoimmune Connective Tissue Diseases
- Fibronektín and R1-Integrin Chain in the Bullous Form ofErythema Exsudativum Multi forme
- Is it Possible to Influence Dermatomycoses by Ecological Means?